Lymphoedema: ICD-10 Codes (I89.0, Q82.0), Staging & Evidence-Based Compression Management in Singapore

What Is Lymphoedema?

Lymphoedema is a chronic condition caused by impaired lymphatic transport, resulting in an abnormal accumulation of protein-rich interstitial fluid in the tissues. Unlike venous oedema — which is predominantly low-protein — lymphoedematous fluid is rich in protein, growth factors, and inflammatory mediators. This composition drives a progressive pathological sequence:

1. Lymphatic transport failure → protein-rich fluid accumulates in interstitium
2. Chronic inflammation → recruitment of macrophages and fibroblasts
3. Fibrosis and adipogenesis → permanent tissue remodelling
4. Lymphostatic elephantiasis (Stage III) → irreversible limb enlargement with skin changes

Untreated, lymphoedema carries a significant burden: recurrent cellulitis, functional impairment, psychological distress, and reduced quality of life. Cellulitis episodes in turn damage remaining lymphatic vessels, creating a vicious cycle of progressive deterioration.

ICD-10 Codes for Lymphoedema

Primary vs Secondary Lymphoedema: Classification

ISL Staging: How Is Lymphoedema Staged?

The International Society of Lymphology (ISL) Consensus Document (2016, updated 2020) defines four stages of lymphoedema based on clinical presentation and tissue characteristics.

Stemmer's Sign — inability to pinch and lift a fold of skin at the base of the second toe (or second finger) — is a reliable clinical sign of lymphoedema, differentiating it from pure venous oedema.

Differential Diagnosis: Lymphoedema vs Lipoedema vs Venous Oedema

Complete Decongestive Therapy (CDT): The Gold Standard

CDT is the internationally recognised evidence-based treatment for lymphoedema at all stages. It is endorsed by the ISL Consensus Document, the Lymphoedema Framework Best Practice Document, and multiple systematic reviews. A 2024 expert consensus document on CDT Phase 1 (published in Medical Oncology) reaffirmed its core components and sequencing.

Phase 1 — Intensive Decongestive Phase (typically 2–8 weeks)

• Manual Lymphatic Drainage (MLD) — specialised gentle massage technique that stimulates remaining lymphatic vessels and redirects lymph flow to functioning lymphatic territories via collateral pathways. Performed by a certified therapist 3–5 times per week.
• Multi-Layer Lymphoedema Bandaging (MLLB) — short-stretch bandages applied in multiple layers from distal to proximal immediately after MLD to maintain volume reduction during the day and exercise.
• Therapeutic exercises — performed while bandaged to augment lymphatic pumping through muscle contraction.
• Meticulous skin care — daily moisturisation with low-pH emollients, inspection for skin breaks, infection prevention (intact skin is the primary defence against cellulitis).

Phase 2 — Self-Management / Maintenance Phase (lifelong)

• Compression hosiery — worn daily from waking to sleeping; replaces bandaging once limb volume is stable.
• Self-MLD — patient-performed simplified MLD taught by therapist; reinforces lymphatic flow patterns established in Phase 1.
• Continued exercises — routine prescribed exercise programme.
• Skin care — daily routine continued indefinitely.

Studies report 30–70% reduction of excess limb volume during the intensive Phase 1 CDT. A systematic review of systematic reviews on CDT for upper extremity breast cancer-related lymphoedema (Springer, 2024) confirmed CDT's effectiveness, though the individual contribution of MLD within CDT remains subject to ongoing study.

Compression Hosiery: Selection Principles

Important safety note: Before applying any compression garment to the lower limb, Ankle-Brachial Pressure Index (ABPI) must be assessed if peripheral arterial disease (PAD) is suspected. Compression is contraindicated in patients with ABPI <0.5 and should be used with caution in ABPI 0.5–0.8.

Low-Level Laser Therapy (LLLT)

LLLT (also called photobiomodulation) has an evidence base for post-mastectomy lymphoedema. A Cochrane review (Huang et al., 2013) found that LLLT significantly reduced excess limb volume and tissue hardness compared to sham treatment in breast cancer-related lymphoedema. LLLT is thought to stimulate lymphangiogenesis and reduce fibrosis. It is offered as an adjunct to CDT at specialist lymphoedema centres; it does not replace compression or MLD.

Skin Care: Preventing Cellulitis in Lymphoedema

Cellulitis is the most common acute complication of lymphoedema and the most important driver of disease progression. Each episode causes additional lymphatic damage. Key skin care principles:

• Daily emollient application — use a low-pH, fragrance-free moisturiser (e.g. aqueous cream, E45, or urea-based emollient) to maintain skin barrier function. Dry, cracked skin is the entry portal for Streptococcal cellulitis.
• Treat any breach in skin integrity promptly — even minor cuts, insect bites, or nail care injuries can trigger cellulitis in a lymphoedematous limb.
• Patients with two or more cellulitis episodes per year should be considered for prophylactic low-dose penicillin V (or erythromycin in penicillin-allergic patients).
• Avoid blood pressure measurement, venepuncture, and injections in the affected limb.

Singapore Context: Lymphoedema Burden and Services

Breast cancer is the most common female cancer in Singapore, accounting for approximately 29.6% of female cancers and affecting 1 in 12 women (Singapore Cancer Registry data). With an age-standardised incidence rate that has risen significantly over the past two decades, the number of breast cancer survivors — and therefore the number at risk of post-mastectomy lymphoedema (ICD-10: I97.2) — continues to grow.

Post-mastectomy lymphoedema affects an estimated 20–30% of women who undergo axillary lymph node dissection (ALND), and 5–7% of those undergoing sentinel lymph node biopsy (SLNB). Risk factors include radiotherapy to the axilla, obesity, infection, and delayed initiation of physiotherapy. Early referral to a lymphoedema therapist in the immediate post-operative period significantly reduces progression to chronic lymphoedema.

Lymphoedema services in Singapore are available at:

• Singapore General Hospital (SGH) — physiotherapy-led lymphoedema clinic
• National University Hospital (NUH) Lymphoedema Service — dedicated lymphoedema team
• KK Women's and Children's Hospital (KKH) — post-breast cancer rehabilitation
• Tan Tock Seng Hospital (TTSH) — physiotherapy and rehabilitation services
• Mount Elizabeth Hospital / Parkway Cancer Centre — private lymphoedema therapy

Under CHAS (Community Health Assist Scheme) and the Chronic Disease Management Programme (CDMP), patients with lymphoedema secondary to chronic conditions may be eligible for Medisave withdrawal for outpatient treatment. MediShield Life covers inpatient hospitalisation when cellulitis requires admission. Patients are advised to retain their ICD-10 code documentation (I97.2, I89.0, or Q82.0) for insurance claim purposes.

Compression Products at EMIS+

Frequently Asked Questions

Is lymphoedema curable?

Primary lymphoedema and Stage II–III secondary lymphoedema are not curable — the underlying lymphatic damage is permanent. However, with consistent CDT and lifelong compression therapy, most patients achieve significant reduction in limb size, prevention of progression, and a good quality of life. Stage I lymphoedema, if identified early and treated promptly, can be maintained in a near-normal state for years.

Does MediShield Life cover lymphoedema treatment in Singapore?

MediShield Life covers inpatient hospitalisation costs, including admission for acute cellulitis complicating lymphoedema. Outpatient physiotherapy and compression garments are generally out-of-pocket or covered through private insurance riders. CHAS subsidies may apply for GP consultations related to lymphoedema management under chronic disease programmes. Patients should retain ICD-10 codes I89.0 or I97.2 on their medical documentation for insurance purposes.

How is lymphoedema different from normal post-surgical swelling?

Post-surgical swelling (oedema) typically resolves within 4–8 weeks as tissue heals and inflammation subsides. Lymphoedema persists beyond this period, worsens with dependent positioning, does not fully resolve with elevation, and is associated with a feeling of heaviness, tightness, or reduced range of motion. Any persistent swelling 3 months post-surgery warrants formal lymphoedema assessment.

Can exercise worsen lymphoedema?

No — when performed correctly and with appropriate compression garments, exercise is beneficial and is a core component of CDT. The International Society of Lymphology and multiple RCTs confirm that resistance and aerobic exercise do not worsen lymphoedema and can improve limb volume and quality of life. Patients should wear their compression garment during exercise.

References

1. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2016 Consensus Document of the International Society of Lymphology. Lymphology. 2016;49(4):170–184. Updated 2020.
2. Lymphoedema Framework. Best Practice for the Management of Lymphoedema. International Consensus. London: MEP Ltd; 2006.
3. Lasinski BB, McKillip Thrift K, Squire D, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. Phys Ther. 2012;92(12):1495–1521.
4. Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer. 2011;19(6):853–857.
5. Huang TH, Liu PH, Chen YH, Tsai YJ. Effectiveness of low-level laser therapy for post-mastectomy lymphedema: a systematic review and meta-analysis. Cochrane Database Syst Rev. 2013.
6. Ezzo J, Manheimer E, McNeely ML, et al. Manual lymphatic drainage for lymphedema following breast cancer treatment. Cochrane Database Syst Rev. 2015.
7. Forte AJ, Boczar D, Huayllani MT, et al. Complete decongestive therapy phase 1: an expert consensus document. Med Oncol. 2024;41(11). doi:10.1007/s12032-024-02407-4.
8. Singapore Cancer Registry. Cancer Trends Report 2003–2022. National Registry of Diseases Office (NRDO), Singapore.
9. ISL. Staging of Lymphedema. Lymphology. 2020;53(1):3–19.
10. Lee BB, Bergan J, Rockson SG (eds). Lymphedema: A Concise Compendium of Theory and Practice. 2nd ed. London: Springer; 2018.